Postoperative Radioiodine not beneficial in Low-Risk Thyroid Cancer patients: ESTIMABL2 Trial Medha Baranwal1 Dec 2024 9:45 PM ISTFrance: A recent study has found that a non-radioiodine follow-up strategy is non-inferior to postoperative radioactive iodine (131I) treatment in...
Real-World Data Confirms 1-Year Serum Thyroglobulin Levels as Reliable for Thyroid Cancer Follow-Up Medha Baranwal25 Sept 2024 8:00 AM ISTItaly: A real-world analysis published in The Journal of Clinical Endocrinology & Metabolism has provided new insights into using serum...
Patients with low-Risk Thyroid Cancer don't benefit with RadioIodine MD Bureau12 March 2022 9:30 AM ISTAfter thyroidectomy, radioiodine (iodine-131) is generally administered both to ablate residual normal thyroid tissue and to treat persistent disease....
